Archer Investment Corp - EAGLE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Archer Investment Corp ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,520
-3.1%
350
+19.5%
0.00%0.0%
Q2 2023$5,696
-31.5%
2930.0%0.00%
-33.3%
Q1 2023$8,3122930.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 3,652,284$302,920,00091.10%
Hudson Executive Capital LP 1,901,200$157,686,00021.62%
JW Asset Management, LLC 525,755$43,606,0009.08%
Cormorant Asset Management, LP 200,000$16,588,0002.41%
Park West Asset Management LLC 488,128$40,485,0002.36%
Opaleye Management Inc. 50,000$4,147,0002.06%
Ranger Investment Management 283,954$23,551,0001.71%
Pier Capital, LLC 74,732$6,198,0001.06%
Bellevue Group AG 67,700$5,615,0000.75%
Orbimed Advisors 671,000$55,653,0000.63%
View complete list of EAGLE PHARMACEUTICALS INC shareholders